Anugerah Pharmindo Lestari
Anugerah Pharmindo Lestari, often referred to as APL, is a prominent player in the pharmaceutical industry, headquartered in Indonesia. Established in 1998, the company has made significant strides in the healthcare sector, focusing on the development, manufacturing, and distribution of high-quality pharmaceutical products. With a strong presence in major operational regions across Southeast Asia, APL is dedicated to enhancing healthcare accessibility. The company offers a diverse range of core products, including prescription medications and over-the-counter solutions, distinguished by their commitment to quality and innovation. Anugerah Pharmindo Lestari has achieved notable market recognition, positioning itself as a trusted name in the industry, known for its adherence to international standards and regulatory compliance. Through continuous growth and development, APL remains dedicated to improving health outcomes across the region.
DitchCarbon Score
How does Anugerah Pharmindo Lestari's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Anugerah Pharmindo Lestari's score of 2 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Anugerah Pharmindo Lestari's reported carbon emissions
In 2023, Anugerah Pharmindo Lestari reported total carbon emissions of approximately 4,406,100 kg CO2e, comprising 598,700 kg CO2e from Scope 1 and 3,807,400 kg CO2e from Scope 2 emissions. This marks a reduction from 2022, where total emissions were about 4,658,600 kg CO2e, with Scope 1 emissions at 625,400 kg CO2e and Scope 2 at 4,033,200 kg CO2e. The company has shown a consistent effort to lower its carbon footprint, with emissions decreasing from 4,566,400 kg CO2e in 2021. Despite these reductions, Anugerah Pharmindo Lestari has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company continues to focus on improving its energy efficiency, as indicated by its reported energy intensity metrics. Overall, Anugerah Pharmindo Lestari is actively working towards minimising its environmental impact, although further commitments and targets would enhance its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 613,300 | 000,000 | 000,000 |
| Scope 2 | 3,953,100 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Anugerah Pharmindo Lestari is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
